Related Experiment Video
Updated: Mar 30, 2026

09:55
Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts
Published on: May 16, 2020
4.2K
Conserved Ductular Reaction Mechanisms in Biliary Atresia and Primary Sclerosing Cholangitis Derived From Single-Cell
A Schofield1, B M Kamath2, S A MacParland3
1Department of Immunology and Immunotherapy, School of Infection, Inflammation, and Immunology, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom.
Cellular and Molecular Gastroenterology and Hepatology
|March 28, 2026
Summary
Primary sclerosing cholangitis (PSC) and biliary atresia (BA) share common ductular reaction (DR) mechanisms, offering therapeutic targets for fibro-inflammatory disorders. Understanding these conserved pathways is key to developing new treatments.
Area of Science:
- Hepatology and immunology
- Fibro-inflammatory disease mechanisms
Background:
- Primary sclerosing cholangitis (PSC) and biliary atresia (BA) exhibit a ductular reaction (DR), a key feature in liver fibrotic diseases.
- Recent advancements in single-cell RNA sequencing and spatial transcriptomics have provided novel insights into the DR's complex cellular and molecular landscape.
Purpose of the Study:
- To elucidate conserved and distinct fibro-inflammatory mechanisms in the ductular reaction of PSC and BA.
- To identify shared pathways amenable to therapeutic targeting across different fibro-inflammatory liver diseases.
Main Methods:
- Utilized single-cell RNA sequencing and spatial transcriptomics to analyze the cellular composition and interactions within the DR niche.
- Compared epithelial, mesenchymal, and immune cell profiles in both PSC and BA patient samples.
Main Results:
- Identified shared pro-fibrogenic processes including hepatocyte-to-cholangiocyte transdifferentiation, cholangiocyte senescence, and macrophage accumulation in both PSC and BA.
- Revealed distinct adaptive immune responses, such as Th17 axis dominance in PSC versus Th1 differentiation in BA.
- Highlighted differences in specific immune cell populations like CD8/NKT cells and lymphocyte homing patterns.
Conclusions:
- PSC and BA share conserved innate immune and mesenchymal pathways in the DR, presenting opportunities for cross-disease therapeutic strategies.
- Distinct adaptive immune responses suggest disease-specific therapeutic considerations.
- Future research should incorporate diverse disease stages and advanced spatial transcriptomics for precise target identification.

